Testosteron deficiency, TRT & Longevity - but done right: In this episode, Dr. Jonathan Apasu speaks with Dr. Eveline Urselmann about the reality behind testosterone replacement therapy. How is the diagnosis really made? Which blood values are crucial and why are reference ranges often misleading? Eveline explains why therapy is a process (feedback, controls, adjustments), which application forms she prefers, and how to recognize an overdose early, often psychologically and first in the social environment.
Also: Why supplements rarely "save" testosterone, which longevity components she still optimizes (Vitamin D, Omega-3, trace elements, cardiovascular markers), and when even statins can temporarily be a topic. Finally, it gets controversial: growth hormone in the longevity approach. Target values like those of a 28-35-year-old, possible benefits, open risk questions, and why it's so expensive.
Topics of this episode:
- Diagnosis: anamnesis, questionnaire, blood sampling and "optimal ranges" vs. reference values
- TRT in practice: IM injection vs. gel (compounding) and what works for whom
- Why patients often don't notice overdose themselves (psyche, behavior, environment)
- Hematocrit/hemoglobin: the safety checkpoint under TRT
- Supplements and Longevity: What really helps and what is wishful thinking?
- Growth hormone: use, target values, benefits, risks and costs
If you don't just want to "do" TRT, but understand it, listen in!



Spotify
Apple Music
YouTube